Germany Congestive Heart Failure Treatment Devices Market Size & Outlook
Related Markets
Germany congestive heart failure treatment devices market highlights
- The Germany congestive heart failure treatment devices market generated a revenue of USD 367.3 million in 2024 and is expected to reach USD 518.6 million by 2030.
- The Germany market is expected to grow at a CAGR of 6% from 2025 to 2030.
- In terms of segment, implantable cardioverter defibrillators was the largest revenue generating product in 2024.
- Ventricular Assist Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Congestive heart failure treatment devices market data book summary
| Market revenue in 2024 | USD 367.3 million |
| Market revenue in 2030 | USD 518.6 million |
| Growth rate | 6% (CAGR from 2025 to 2030) |
| Largest segment | Implantable cardioverter defibrillators |
| Fastest growing segment | Ventricular Assist Devices |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ventricular Assist Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy, Counter Pulsation Devices |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Abbott Laboratories, Jarvik Heart, ReliantHeart, Biotronik SE & Co., KG, Berlin Heart GmbH |
Other key industry trends
- In terms of revenue, Germany accounted for 6.6% of the global congestive heart failure treatment devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany congestive heart failure treatment devices market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 348.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Congestive Heart Failure Treatment Devices Market Scope
Congestive Heart Failure Treatment Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ReliantHeart | View profile | 11-50 | Houston, Texas, United States, North America | http://reliantheart.com |
| Biotronik SE & Co., KG | View profile | - | - | - |
| Jarvik Heart | View profile | 51-100 | New York, New York, United States, North America | https://www.jarvikheart.com/ |
| Berlin Heart GmbH | View profile | 501-1000 | Berlin, Berlin, Germany, Europe | http://www.berlinheart.de/ |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Germany congestive heart failure treatment devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to congestive heart failure treatment devices market will help companies and investors design strategic landscapes.
Implantable cardioverter defibrillators was the largest segment with a revenue share of 33.68% in 2024. Horizon Databook has segmented the Germany congestive heart failure treatment devices market based on ventricular assist devices, implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy, counter pulsation devices covering the revenue growth of each sub-segment from 2018 to 2030.
As per the Organization for Economic Cooperation, in Germany, more than 310 per 100,000 people die of cardiovascular diseases each year. There are several causes for coronary diseases, including genetics and natural aging, but smoking, obesity, high cholesterol, and diabetes can increase the associated risks.
Thus, there is a high demand for cardiovascular solutions including CHF treatment. With the oldest national social health insurance system, the German healthcare system is considered as the pioneering one in public health support. Moreover, schemes such as statutory health insurance are strengthening the healthcare infrastructure, thus encouraging individuals to undergo advanced treatment.
Reasons to subscribe to Germany congestive heart failure treatment devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Germany congestive heart failure treatment devices market databook
-
Our clientele includes a mix of congestive heart failure treatment devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany congestive heart failure treatment devices market, including forecasts for subscribers. This country databook contains high-level insights into Germany congestive heart failure treatment devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Germany congestive heart failure treatment devices market size, by ventricular assist devices, 2018-2030 (US$M)
Germany Congestive Heart Failure Treatment Devices Market Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
